Description
Vitiligo Treatment Market Analysis
Market Overview
The Vitiligo Treatment Market is projected to register a CAGR of 6.20% during the review period. Vitiligo is a persistent dermatological problem portrayed by skin depigmentation brought about by the failing or demise of the skin’s color-delivering cells known as melanocytes. Accordingly, distinct white patches show up on the skin. The circumstances endure, making bigger areas of skin lose color. Treatment might further develop skin appearance yet doesn’t fix the illness. The key factors that drive the worldwide vitiligo treatment market are the developing significance of tasteful allure and mindfulness and the rising commonness of vitiligo cases. the advancement of innovation proposing treatments for treating various difficulties brought about by the confusion, and the pervasiveness of speculations by government bodies in medical care foundation speeds up the market development.
Lately, there is a huge ascent in excellence cognizance among customers inferable from the developing mindfulness among shoppers about various style treatments, expanding per capita pay, and reception of computerized stages. As per the Global Society of Stylish Plastic Medical procedure (ISAPS), there was a 27.3% development in overall complete non-surgeries somewhere in the range between 2015 and 2019. Furthermore, as indicated by the American Culture of Plastic Specialists (ASPS), the quantity of negligibly intrusive tasteful systems saw about a 200% expansion during 2000-2017. Besides, around 15.9 million negligibly obtrusive restorative methods were acted in 2018, which was a 2% ascent in contrast with 2017. Subsequently, the rising geriatric populace additionally drives the interest in negligibly obtrusive restorative methodology.
Segment Overview
By Type, the vitiligo treatment market is divided into Segmental vitiligo and non-segmental vitiligo. By Treatment Type, the market is classified into Surgery, Therapy, and Medication.
By the End-User industry, the market is divided into Ambulatory Clinics, Hospitals, and Others.
Regional Analysis
North America ruled the worldwide vitiligo treatment market in 2021, owing to the presence of repayment exercises and the developing significance of tasteful allure likewise adding to regional market development.
As per the article distributed in the Diary of the European Foundation of Dermatology and Venereology (JEADV), the online-populace-based study exhibited that the commonness of vitiligo was 1.3% in Europe. Additionally, mechanical progressions in vitiligo treatment strategies are being taken on in the region because of the number of individuals languishing.
The vitiligo treatment market in Asia-Pacific is driven by an expansion in the number of innovative work exercises and developing interest in vitiligo treatment choices. For example, as indicated by the Indian Dermatology Online Diary (IDOJ), a cross-sectional review was led among 200 patients with vitiligo, the review expresses that 16.5% of people had segmental vitiligo, while 83.5% had non-segmental vitiligo. Besides, the ascent in the number of drives embraced by different public and confidential associations as acquisitions, joint efforts, administrative endorsements, and interests in this region is helping the market development.
Major Players
Incyte (US), Koninklijke Philips N.V. (Netherlands), Bausch Health Companies Inc. (Canada), Reddy’s Laboratories Ltd. (India), STRATA Skin Sciences (US), Clinuvel Pharmaceuticals Ltd (Australia), Roivant Sciences Ltd. (Switzerland), ISSAR Pharmaceuticals Pvt. Ltd. (India), Kernel Medical Equipment Co., LTD. (China), and LightSource (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
1.1.1 MARKET SYNOPSIS
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 LIST OF ASSUMPTIONS
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA MINING
3.3 SECONDARY RESEARCH
3.4 PRIMARY RESEARCH
3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 GROWING IMPORTANCE OF THE AESTHETIC APPEAL AND AWARENESS
4.2.2 INCREASING PREVALENCE OF VITLIGO
4.3 RESTRAINTS
4.3.1 LACK OF TRAINED PROFESSIONALS
4.4 OPPORTUNITIES
4.4.1 RISING NUMBER OF CLINICAL TRIALS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE VITILIGO TREATMENT MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON REGION
5.3.3 IMPACT ON DEMAND AND SUPPLY
6 GLOBAL VITILIGO TREATMENT MARKET, BY TYPE
6.1 OVERVIEW
6.2 SEGMENTAL VITILIGO
6.3 NON-SEGMENTAL VITILIGO
7 GLOBAL VITILIGO TREATMENT MARKET, BY TREATMENT TYPE
7.1 OVERVIEW
7.2 THERAPY
7.2.1 DEPIGMENTATION
7.2.2 LIGHT
7.3 SURGERY
7.3.1 SKIN GRAFTING
7.3.2 BLISTER GRAFTING
7.3.3 MICRO-PIGMENTATION
7.4 MEDICATION
7.4.1 TOPICAL CORTICOSTEROIDS
7.4.2 IMMUNOSUPPRESSIVE
8 GLOBAL VITILIGO TREATMENT MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 AMBULATORY CLINICS
8.4 OTHERS
9 GLOBAL VITILIGO TREATMENT MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 SOUTH KOREA
9.4.5 AUSTRALIA
9.4.6 REST OF ASIA-PACIFIC
9.5 REST OF THE WORLD
9.5.1 MIDDLE EAST
9.5.2 AFRICA
9.5.3 LATIN AMERICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN VITILIGO TREATMENT MARKET
10.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN VITILIGO TREATMENT MARKET
10.5 KEY DEVELOPMENT ANALYSIS
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 PRODUCT APPROVALS/PRODUCT LAUNCHES/DRUG PIPELINE
10.6.2 MERGERS & ACQUISITIONS
10.7 MAJOR PLAYERS SALES ANALYSIS
10.7.1 SALES & OPERATING INCOME, 2021
10.7.2 MAJOR PLAYERS R&D ANALYSIS, 2021
11 COMPANY PROFILE
11.1 INCYTE
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 BAUSCH HEALTH COMPANIES INC.
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 KONINKLIJKE PHILIPS N.V.
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 DR. REDDY’S LABORATORIES LTD.
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 STRATA SKIN SCIENCES
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 KEY STRATEGIES
11.6 CLINUVEL PHARMACEUTICALS LTD
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 SWOT ANALYSIS
11.6.6 KEY STRATEGIES
11.7 ISSAR PHARMACEUTICALS PVT. LTD.
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL ANALYSIS
11.7.3 PRODUCTS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIES
11.8 KERNEL MEDICAL EQUIPMENT CO., LTD.
11.8.1 COMPANY OVERVIEWS
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIES
11.9 LIGHTSOURCES
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL ANALYSIS
11.9.3 PRODUCTS OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIES
11.10 ROIVANT SCIENCES LTD.
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL ANALYSIS
11.10.3 PRODUCTS OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 PRODUCTS OFFERED
11.10.6 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS
Reviews
There are no reviews yet.